The False Claims Act (FCA), a cornerstone of anti-fraud legislation, has been instrumental in recouping billions of dollars for the US government. This comprehensive guide by Young Law Group delves into the complexities of qui tam lawsuits, the perils of whistleblower retaliation, and recent trends shaping FCA litigation. The FCA’s Staggering Financial Impact The FCA has proven...
On February 8, 2023, California Attorney General Rob Bonta announced that Centene Corporation agreed to pay $215 million to settle allegations that the company and its Pharmacy Benefit Manager violated the California False Claims Act by committing prescription drug fraud against Medi-Cal. Specifically, the California Department of Justice alleged that Centene submitted false reports of...
Plastic Surgery Whistleblowers Secure Large Payout A Beverly Hills plastic surgeon, in collaboration with his son, have agreed to pay $23.9 million to address accusations of violating the False Claims Act. The allegations revolve around their alleged involvement in submitting or facilitating the submission of fraudulent claims to Medicare and Medicaid. The state of California,...
COVID Fraud on the Rise From March 2020 through January 13, 2023, at least 1,044 individuals pleaded guilty or were convicted of defrauding COVID-19 relief programs, according to a recent study by the Government Accountability Office (GAO). Fraudsters’ biggest targets were two loan programs administered by the Small Business Administration (SBA) — the Paycheck Protection Program (PPP)...
Incentives for Whistleblowers The Department of Justice announced that INSYS Therapeutics, Inc. (“INSYS”) has agreed to pay $225 million to resolve allegations that it paid kickbacks and engaged in other illegal marketing tactics to promote sales of its fentanyl spray, Subsys. According to the terms of the settlement, INSYS will pay a criminal fine of...
On October 2, 2019, Retina Institute of California Medical Group (RIC), along with its former CEO and several physicians, agreed to pay $6.65 million to resolve allegations of False Claims Act violations. RIC is a medical partnership of ophthalmologists with multiple locations in California. The medical group was alleged to have defrauded government health care programs...
INSYS Agrees to Global Resolution of Claims Arising from Separate DOJ Criminal and Civil Investigations The Department of Justice announced that INSYS Therapeutics, Inc. (“INSYS”) has agreed to pay $225 million to resolve allegations that it paid kickbacks and engaged in other illegal marketing tactics to promote sales of its fentanyl spray, Subsys. According to...
Genetic Testing Laboratory Pays $2 Million to Settle Allegations of Medicare Fraud The Justice Department announced a settlement last month with GenomeDx Biosciences Corp. (“GenomeDx”), a genetic testing laboratory based in Vancouver, British Columbia with offices in San Diego. GenomeDx agreed to pay nearly $2 million to resolve alleged violations of the False Claims Act. According to the...
5G implementation is proceeding straightaway despite serious concerns raised by numerous credible researchers and scientists. The next generation of cell phone technology could pose serious cancer risks to the public You have probably already heard about 5G and the plans to roll out the new technology over the next two years. 5G is the new...
Drug Fraud Since 2018 A number of civil settlements and criminal convictions involving pharmacy and drug fraud in 2018 have highlighted a longstanding problem that imperils patient health and burdens American taxpayers with costs measured annually in the millions of dollars. Pharmacy and drug fraud takes many different forms and can involve everyone in the...











